Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 1663
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Numelvi 31.6 mg EU/2/25/351/007 Intervet International B.V., Nīderlande QD11AH93 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Atinvicitinib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 24-Jul-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/25/351/007 31,6 mg/tabl. 1 Blisteris, 30 tablete -
BRAVECTO TriUNO - EU/2/24/325/007 Intervet International B.V., Nīderlande QP54AB52 dogs Vairāk

Medicinal product information

Pharmaceutical form: Chewable tablet
International name (active substance): Fluralaner, Moxidectin, Pyrantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 22-Nov-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/24/325/007 1 Blisteris, 1 tablete -
CircoMax Myco - EU/2/20/264/001 Zoetis Belgium S.A., Beļģija QI09AL08 fattening pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a ORF2 protein, Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein, Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 09-Dec-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/20/264/001 1 ABPE flakons, 50 ml -
Semintra 4 mg/ml EU/2/12/146/001 Boehringer Ingelheim Vetmedica GmbH, Vācija QC09CA07 cats Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Telmisartan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Boehringer Ingelheim Pharma GmbH & Co. KG, Vācija
Date of authorisation/renewal: 28-Feb-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/12/146/001 4 mg/ml 1 Flakons, 30 ml -
LETIFEND - EU/2/16/195/005 Laboratorios LETI, S.L. unipersonal, Spānija QI07A dogs Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for solution for injection
International name (active substance): Recombinant Protein Q from Leishmania infantum MON-1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 20-Apr-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/16/195/005 20 Stikla flakons, 1 deva -
Porcilis Porcoli Diluvac Forte - EU/2/96/001/008 Intervet International Booxmer, Nīderlande QI09AB02 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,LT toxoid,F4ac (K88ac) fimbrial adhesin,F6 (987P) fimbrial adhesin
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 10-Apr-2006
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/96/001/008 1 Flakons, 100 ml -
Syvazul BTV - EU/2/18/231/003 Laboratorios SYVA S.A.U, Spānija QI04AA02 cattle; sheep Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated bluetongue virus, serotype 4, strain SPA-1/2004
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release LABORATORIOS SYVA, S.A.U. , Spānija
Date of authorisation/renewal: 09-Jan-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/18/231/003 1 Polipropilēna flakons, 80 ml -
APOQUEL 16 mg EU/2/13/154/036 Zoetis Belgium S.A., Beļģija QD11AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: Chewable tablet
International name (active substance): Oclacitinib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 04-Jul-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/13/154/036 16 mg 5 Blisteris, 10 tablete -
Metacam 20 mg/ml EU/2/97/004/027 Boehringer Ingelheim Vetmedica GmbH, Vācija QM01AC06 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 06-Dec-2007
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/97/004/027 20 mg/ml 1 Stikla flakons, 20 ml -
Advocate Spot-on maziem kaķiem un seskiem - EU/2/03/039/019 Bayer Animal Health , Vācija QP54AB52 ferrets; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Moxidectin,Imidacloprid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 01-Apr-2003
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/03/039/019 21 Pipete, 0,4 ml -
Equip WNV - EU/2/08/086/004 Zoetis Belgium S.A., Beļģija QI05AA10 horses Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated West Nile V, strain VM-2
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 12-Sep-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/08/086/004 2 Stikla pilnšļirce ar 1 adatu, 1 ml -
Startvac - EU/2/08/092/002 Laboratorios Hipra S.A., Spānija QI02AB cattle Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Staphylococcus aureus,Inactivated Escherichia coli
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Hipra S.A., Spānija
Date of authorisation/renewal: 13-Feb-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/08/092/002 10 Stikla pudelīte, 1 deva -
Imoxat 80 mg EU/2/21/280/008 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QP54AB52 ferrets; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 27-Jan-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/21/280/008 1 Pipete, 0,8 ml -
Proteq West Nile - EU/2/11/129/002 Boehringer Ingelheim Vetmedica GmbH, Vācija QI05AX horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Live recombinant canarypox virus
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal: 17-May-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/11/129/002 1 devas/flakonā 2 Flakons, 1 deva -
Fluralaner Intervet 400 mg EU/2/25/346/013 Intervet International B.V., Nīderlande QP53BE02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Fluralaner
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 27-Jun-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/25/346/013 1 Blisteris, 1 tablete -
Porcilis PCV M Hyo ID - EU/2/24/319/006 Intervet International B.V., Nīderlande QI09AL08 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Porcine circovirus type 2, ORF2 capsid protein
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release -
Date of authorisation/renewal: 30-Aug-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/24/319/006 10 PET flakons, 100 deva -
Equilis Te - EU/2/05/055/002 Intervet International Booxmer, Nīderlande QI05AB03 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Tetanus toxoid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 12-Jul-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/05/055/002 10 Pilnšļirce, 1 deva -
Onsior 5 mg EU/2/08/089/007 Elanco GmbH, Vācija QM01AH91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Robenacoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
Date of authorisation/renewal: 15-Dec-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/08/089/007 5 mg/tabl. 70 Alumīnija blisteris, 1 tablete -
CircoMax - EU/2/21/281/004 Zoetis Belgium S.A., Beļģija QI09AA07 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a ORF2 protein, Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 11-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/21/281/004 10 ABPE flakons, 50 ml -
Vectra 3D - EU/2/13/156/031 Ceva Sante Animale, Francija QP53AC54 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Permethrin,Pyriproxyfen,Dinotefuran
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 27-Aug-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: EU
Package leaflet: * -
Labelling text: * -
Summary of product characteristics: * -
* More detailed information available on the European Medicines Agency website

Products

ID Strength Package size Primary packaging Labelling
EU/2/13/156/031 24 Polipropilēna aplikators, 1 deva -

3081 record